Evidence map›Paper›PMID 31769564›Full record

ArticleBrain pathology (Zurich, Switzerland)2020

The neuroprotective role of microglial cells against amyloid beta-mediated toxicity in organotypic hippocampal slice cultures.

Maren Richter, Natascha Vidovic, Knut Biber, Amalia Dolga, Carsten Culmsee, Richard Dodel

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Amyloid-Beta, Tau, and Microglial Activation in Aged Felid Brains.The Journal of comparative neurology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Frontiers in molecular neuroscience · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maren RichterDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.
Natascha VidovicDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.ORCID 0000-0002-1426-7625
Knut BiberMolecular Psychiatry, Psychiatric Hospital, University of Freiburg, Freiburg, Germany.
Amalia DolgaInstitute for Pharmacology and Clinical Pharmacy, Philipps-University Marburg, Marburg, Germany.ORCID 0000-0001-5400-5614
Carsten CulmseeInstitute for Pharmacology and Clinical Pharmacy, Philipps-University Marburg, Marburg, Germany.ORCID 0000-0002-5121-5015
Richard DodelDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.

Funding

Competence Network Degenerative Dementias (KNDD) and Faber-Stiftung Marburg, Germany. 01GI1008C
6 · The paper itself

Abstract

During Alzheimer's disease (AD) progression, microglial cells play complex roles and have potentially detrimental as well as beneficial effects. The use of appropriate model systems is essential for characterizing and understanding the roles of microglia in AD pathology. Here, we used organotypic hippocampal slice cultures (OHSCs) to investigate the impact of microglia on amyloid beta (Aβ)-mediated toxicity. Neurons in OHSCs containing microglia were not vulnerable to cell death after 7 days of repeated treatment with Aβ

Indexed as

Amyloid beta-PeptidesAnimalsCaspasesCell DeathClodronic AcidHippocampusInterleukin-6MiceMicrogliaNeuroprotectionPeptide FragmentsTumor Necrosis Factor-alphaAmyloid beta-Peptidesamyloid beta-protein (1-42)CaspasesClodronic AcidInterleukin-6Peptide FragmentsTumor Necrosis Factor-alphaAlzheimer’s disease (AD)amyloid beta (Aβ)ER stressmicrogliaorganotypic hippocampal slice cultures

Identifiers

PMID31769564
PMCPMC8018096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.